Thermo Fisher Scientific introduces AmpSure Universal SYBR Green and Probe Master Mixes, offering value-priced qPCR reagents.
Agilent has acquired digital pathology software firm Proscia for $240 million, adding an FDA-cleared platform to its ...
Hepta reports its AI-based blood test matched MRE in identifying treatment-eligible MASH fibrosis in an independent Madrigal ...
Siemens Healthineers will separate its in vitro diagnostics business as Olyrian Diagnostics, aiming to complete the ...
Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...
A study links early donor-derived cell-free DNA patterns to kidney transplant outcomes, including rejection and graft loss.
FDA clears Cepheid’s Xpert Hemorrhagic Fever Panel, a multiplex PCR test for Ebola, Marburg, Lassa, and Crimean-Congo viruses ...
A study found Lucid’s nonendoscopic EsoCheck device achieved a 95% sample collection rate for esophageal precancer testing in ...
A study in Gynecologic Oncology reports that a Mercy BioAnalytics blood test measuring cancer-linked proteins may detect ...
Pillar Biosciences introduces the MRDTect NPM1 and FLT3 ITD NGS panel for in-house acute myeloid leukemia MRD detection.
A Mayo Clinic study of nearly 50,000 adults found many carriers of sickle cell and beta-thalassemia traits were not identified in electronic health records, highlighting gaps in current documentation ...
FDA clears Roche cobas eplex RP3 panel, which detects up to 19 respiratory pathogen and adds Bordetella pertussis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results